Insider Transactions in Q4 2025 at Biodesix Inc (BDSX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 10
2025
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
SELL
Open market or private sale
|
Direct |
50
-0.38%
|
$350
$7.62 P/Share
|
|
Nov 10
2025
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
158
+1.18%
|
-
|
|
Nov 10
2025
|
Scott Hutton President & CEO |
SELL
Open market or private sale
|
Direct |
189
-0.5%
|
$1,323
$7.62 P/Share
|
|
Nov 10
2025
|
Scott Hutton President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
611
+1.6%
|
-
|
|
Nov 10
2025
|
Kieran O'Kane Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
25
-0.34%
|
$175
$7.62 P/Share
|
|
Nov 10
2025
|
Kieran O'Kane Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75
+1.01%
|
-
|
|
Nov 10
2025
|
Gary Anthony Pestano Chief Development Officer |
SELL
Open market or private sale
|
Direct |
23
-0.29%
|
$161
$7.62 P/Share
|
|
Nov 10
2025
|
Gary Anthony Pestano Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.86%
|
-
|
|
Nov 10
2025
|
Chris Vazquez Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
13
-1.37%
|
$91
$7.62 P/Share
|
|
Nov 10
2025
|
Chris Vazquez Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31
+3.16%
|
-
|